Eddy K, Chen S. Overcoming immune evasion in melanoma. Int J Mol Sci. 2020;21(23):8984.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crawford NG, Kelly DE, Hansen MEB, et al. Loci associated with skin pigmentation identified in African populations. Sci. 2017;358(6365):eaan8433.

Article  Google Scholar 

Lazaroff J, Bolotin D. Targeted Therapy and Immunotherapy in Melanoma. Dermatol Clin. 2023;41(1):65–77.

Article  CAS  PubMed  Google Scholar 

Forsea AM. Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities. Dermatol Pract Concept. 2020;10(3):e2020033.

Article  PubMed  PubMed Central  Google Scholar 

Sabag N, Yakobson A, Retchkiman M, et al. Novel biomarkers and therapeutic targets for melanoma. Int J Mol Sci. 2022;23(19):11656.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmed B, Qadir MI, Ghafoor S. Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment. Crit Rev Eukaryot Gene Expr. 2020;30(4):291–7.

Article  PubMed  Google Scholar 

Kim HJ, Kim YH. Molecular frontiers in melanoma: pathogenesis, diagnosis, and therapeutic advances. Int J Mol Sci. 2024;25(5):2984.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ralli M, Botticelli A, Visconti IC, et al. Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions. J Immunol Res. 2020;2020:9235638.

Article  PubMed  PubMed Central  Google Scholar 

Boutros A, Croce E, Ferrari M, et al. The treatment of advanced melanoma: Current approaches and new challenges. Crit Rev Oncol Hematol. 2024;196:104276.

Article  PubMed  Google Scholar 

Yu P, Wei H, Li K, et al. The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun. J Exp Clin Cancer Res. 2022;41(1):346.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Kuai L, Cui R, et al. Melanogenesis and the targeted therapy of melanoma. Biomol. 2022;12(12):1874.

CAS  Google Scholar 

Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283–98.

Article  CAS  PubMed  Google Scholar 

Luo H, Vong CT, Chen H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48.

Article  PubMed  PubMed Central  Google Scholar 

Taylor E, Kim Y, Zhang K, et al. Antiaging mechanism of natural compounds: Effects on autophagy and oxidative stress. Mol. 2022;27(14):4396.

Article  CAS  Google Scholar 

Wang Q, Yang B, Wang N, Gu J. Tumor immunomodulatory effects of polyphenols. Front Immunol. 2022;13:1041138.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56–61.

Article  CAS  PubMed  Google Scholar 

Nuzzo G, Senese G, Gallo C et al. Antitumor Potential of Immunomodulatory Natural Products. Mar Drugs. 2022;20(6)

Pan Y, Yu Y, Wang X, Zhang T. Tumor-Associated Macrophages in Tumor Immunity. Front Immunol. 2020;11:583084.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xian H, Li J, Zhang Y, et al. Antimetastatic Effects of Ganoderma lucidum Polysaccharide Peptide on B16–F10-luc-G5 Melanoma Mice With Sleep Fragmentation. Front Pharmacol. 2021;12:650216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee DY, Park CW, Lee SJ, et al. Immunostimulating and Antimetastatic Effects of Polysaccharides Purified from Ginseng Berry. Am J Chin Med. 2019;47(4):823–39.

Article  CAS  PubMed  Google Scholar 

Li X, Dong W, Nalin AP, et al. The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells. Oncoimmunology. 2018;7(6):e1431085.

Article  PubMed  PubMed Central  Google Scholar 

Davoodvandi A, Darvish M, Borran S, et al. The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis. Int Immunopharmacol. 2020;88:106905.

Article  CAS  PubMed  Google Scholar 

Ravindran Menon D, Li Y, Yamauchi T, Osborne DG, et al. EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses. Pharm. 2021;14(11):1081.

CAS  Google Scholar 

Xu L, Zhang Y, Tian K, et al. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. J Exp Clin Cancer Res. 2018;37(1):261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu R, Zeng M, Wu Y, et al. Acetone Extract of Cornus officinalis Leaves Exerts Anti-Melanoma Effects via Inhibiting STAT3 Signaling. Onco Targets Ther. 2021;14:3487–501.

Article  PubMed  PubMed Central  Google Scholar 

Sha X, Xu X, Liao S, Chen H, Rui W. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo. Exp Cell Res. 2022;410(1):112948.

Article  CAS  PubMed  Google Scholar 

Li X, He L, Ou Y, et al. Oxymatrine inhibits melanoma development by modulating the immune microenvironment and targeting the MYC/PD-L1 pathway. Int Immunopharmacol. 2023;124(Pt B):111000.

Article  CAS  PubMed  Google Scholar 

Zhang W, Lin L, Zhang Y, et al. Dioscin potentiates the antitumor effect of suicide gene therapy in melanoma by gap junction intercellular communication-mediated antigen cross-presentation. Biomed Pharmacother. 2022;150:112973.

Article  CAS  PubMed  Google Scholar 

Xie G, Dong H, Liang Y, et al. CAR-NK cells: A promising cellular immunotherapy for cancer. EBioMedicine. 2020;59:102975.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lian GY, Wang QM, Tang PM, et al. Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling. Mol Ther. 2018;26(9):2255–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ogasawara M, Yamasaki-Yashiki S, Hamada M, et al. Betulin Attenuates TGF-beta1- and PGE(2)-Mediated Inhibition of NK Cell Activity to Suppress Tumor Progression and Metastasis in Mice. Biol Pharm Bull. 2022;45(3):339–53.

Article  CAS  PubMed  Google Scholar 

Li K, Shi H, Zhang B, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.

Article  PubMed  PubMed Central  Google Scholar 

Gao W, Zhang X, Yang W, et al. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells. J Immunother Cancer. 2019;7(1):231.

Article